# Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

> **NCT05720572** · PHASE4 · UNKNOWN · sponsor: **Centre of Postgraduate Medical Education** · enrollment: 105 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Antazoline
- **DRUG:** Propafenone

## Key facts

- **NCT ID:** NCT05720572
- **Lead sponsor:** Centre of Postgraduate Medical Education
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720572, "Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05720572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*